← Back to Clinical Trials
Recruiting NCT07024420

NCT07024420 Sigh Ventilation in Cardiac Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07024420
Status Recruiting
Phase
Sponsor Zhongda Hospital
Condition Postoperative Pulmonary Complications (PPCs)
Study Type INTERVENTIONAL
Enrollment 686 participants
Start Date 2025-10-09
Primary Completion 2027-11-30

Trial Parameters

Condition Postoperative Pulmonary Complications (PPCs)
Sponsor Zhongda Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 686
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-10-09
Completion 2027-11-30
Interventions
Sigh BreathsLow Tidal VolumeModerate PEEP

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this trial is to investigate whether sigh ventilation strategy, combining sigh breaths, low tidal volume, and moderate PEEP levels, protects against major pulmonary complications within the first 7 postoperative days after cardiac surgery, as compared with conventional ventilation strategy with low tidal volume, and moderate PEEP levels.

Eligibility Criteria

Inclusion Criteria: * 18 years of age or older; * Elective cardiac surgery with cardiopulmonary bypass, aortic clamp and cardioplegia; * Written informed consent is obtained from patients and/or their legal representatives. Exclusion Criteria: * Emergence surgery; * Left ventricular assist device implantation; * Planned thoracotomy with one lung ventilation; * Undergo concurrent surgical procedures outside cardiology; * Neuromuscular illness; * Mechanical ventilation within the last 2 weeks before surgery, include CPAP and NIV; * Preoperative shock; * Preoperative Hypoxemia (PaO2\<60mmHg OR SpO2\<90% on ambient air); * Preoperative left ventricular ejection fraction \< 40%; * Systolic pulmonary artery pressure \> 50 mmHg.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology